Delivery Order SPE2DB24D2205-SPE2DB25FECDF
Award Date
5/9/25
Potential Completion Date
6/2/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,461.32 and an ultimate completion date of June 18, 2024. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Envarsus XR 4 mg tablets. The contract, valued at $19,383.96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of September 20, 2024. This delivery order contract is a firm fixed price arrangement. Amerisourcebergen has been a significant supplier of pharmaceutical and medical products to various government agencies, including...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Envarsus XR 1 mg tablets. The contract, valued at $1,465.68, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to serve the Department of Defense (DoD) and other government agencies. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Envarsus XR 1 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order valued at $1,465.68 with a completion date of September 9, 2024. The contract has no set-aside designation. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
This federal contract award, with ID SPE2DB24D1021|SPE2DB25FERKJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,737.47 fixed-price delivery order is for the supply of Envarsus XR 4 mg tablets. The contract has an ultimate completion date of November 6, 2024 and was awarded on October 16, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, a firm fixed price delivery order contract valued at $1,465.68 for the supply of Envarsus XR 1 mg tablets. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
This federal contract award, with ID SPE2DB25D3018|SPE2DB25FUXJB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,423.90 firm fixed-price delivery order is for the supply of 4,568,040,413 units of the medication Envarsus XR 4 mg tablet. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,423.90 firm fixed-price delivery order is for the supply of 100 units of Envarsus XR 4 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract, valued at $8,076.65, is for the delivery of Envarsus XR 4 mg tablets over a period ending on July 30, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,845.99 firm fixed price delivery order is for the supply of Envarsus XR 4 mg tablets. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...